Camurus AB (CAMX.ST)
CAMX.ST on Stockholm Stock Exchange
94.80SEK
20 Jul 2018
94.80SEK
20 Jul 2018
Change (% chg)
0.40kr (+0.42%)
0.40kr (+0.42%)
Prev Close
94.40kr
94.40kr
Open
93.90kr
93.90kr
Day's High
95.90kr
95.90kr
Day's Low
93.90kr
93.90kr
Volume
10,613
10,613
Avg. Vol
23,766
23,766
52-wk High
147.80kr
147.80kr
52-wk Low
91.30kr
91.30kr
About
Camurus AB is a Sweden-based research and development based pharmaceutical company with a focus on the development and commercialization of specialty medicines, providing patients suffering from serious and chronic disease, such as opioid dependence, pain, cancer, acromegaly, and neuroendocrine tumors. The Company has a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | kr3,623.21 |
| Shares Outstanding(Mil.): | 38.38 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CAMX.ST | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 29.12 | 33.34 |
| EPS (TTM): | -5.59 | -- | -- |
| ROI: | -47.78 | 13.60 | 13.18 |
| ROE: | -47.78 | 15.30 | 15.09 |
BRIEF-Camurus Q4 Operating Loss Widens To SEK 66.1 Million
* Q4 NET SALES SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
BRIEF-Camurus AB Q4 Net Revenue Sek 5.5 Million Versus Sek 37.1 Million Year Ago
* Q4 NET REVENUE SEK 5.5 MILLION VERSUS SEK 37.1 MILLION YEAR AGO
Estimates